Cardiac pacing in patients with neurally mediated syncope and documented asystole: Effectiveness analysis from the Third International Study on Syncope of Uncertain Etiology (ISSUE-3) Registry

Europace

Volumn 16, Issue 4, 2014, Pages 595-599

  Sutton, Richard ^a   Ungar, Andrea ^b   Sgobino, Paolo ^c   Russo, Vitantonio ^d   Massa, Riccardo ^e   Melissano, Donato ^f   Beiras, Xulio ^g   Bottoni, Nicola ^h   Ebert, Hans H ^f   Francese, Maura ⁱ   Jorfida, Marcella ^j   Giuli, Silvia ^k   Moya, Angel ^l   Andresen, Dietrich ^m   Brignole, Michele ⁿ  

^a ST MARY S HOSPITAL   (United Kingdom)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c Ospedale di Bolzano   (Italy)

^d Department of Cardiology   (Italy)

^e C Arrigo Children's Hospital   (Italy)

^f Presidio Ospedaliero di Casarano ^*  (Germany)

^g HOSPITAL XERAL CALDE   (Spain)

^h S MARIA NUOVA HOSPITAL   (Italy)

ⁱ GARIBALDI HOSPITAL   (Italy)

^j MOLINETTE HOSPITAL   (Italy)

^k Medtronic Italia   (Italy)

^l HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^m VIVANTES KLINIKUM AM URBAN   (Germany)

ⁿ DEPARTMENT OF CARDIOLOGY   (Italy)

more..

Author keywords

Cardiac pacing; Loop recorder; Neurally mediated syncope; Pacemaker; Syncope

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE REGISTRY; FAINTNESS; FEMALE; FOLLOW UP; HAZARD RATIO; HEART ARREST; HEART PACING; HEMATOTHORAX; HUMAN; HYPERTENSION; IMPLANTABLE CARDIAC MONITOR; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MIDDLE AGED; MULTICENTER STUDY; NEURALLY MEDIATED SYNCOPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; RISK REDUCTION; TREATMENT DURATION; AGED; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; EQUIPMENT DESIGN; INTENTION TO TREAT ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; REGISTER; SYNCOPE; TIME; TREATMENT OUTCOME;

AGED; CARDIAC PACING, ARTIFICIAL; DOUBLE-BLIND METHOD; EQUIPMENT DESIGN; HEART ARREST; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; REGISTRIES; SYNCOPE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84898927329     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut323     Document Type: Article

References (13)

1. Brignole M, Menozzi C, Moya A, Andresen D, Blanc JJ, Krahn AD, et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): A randomized trial. Circulation 2012;125:2566-71
2. Brignole M. International study on syncope of uncertain aetiology 3 (ISSUE 3): Pacemaker therapy for patients with asystolic neurally-mediated syncope: Rationale and study design. Europace 2007;9:25-30
3. Brignole M, Alboni P, Benditt DG, Bergfeldt L, Blanc JJ, Thomsen PE, et al. Guidelines on management (diagnosis and treatment) of syncope-update 2004. Europace 2004;6:467-537
4. Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30:2631-71
5. Brignole M, MoyaA, Menozzi C, Garcia-CiveraR, Sutton R. Proposed electrocardiographic classification of spontaneous syncope documented by an implantable loop recorder. Europace 2005;7:14-8
6. The Steering Committee of the ISSUE 3 Study. International study on syncope of uncertain aetiology 3(ISSUE 3): Pacemaker therapy for patients with asystolic neurallymediated syncope: Rationale and study design. Europace 2007;9:25-30
7. Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, WielingWet al. Early application of an implantable loop recorder allows a mechanism-based effective therapy in patients with recurrent suspected neurally-mediated syncope. Eur Heart J 2006;27:1085-92
8. Connolly SJ, Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL, et al. for the VPS II investigators. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II). JAMA 2003;289:2224-9
9. Raviele A, Giada F, Menozzi C, Speca G, Orazi S, Gasparini G, et al. The vasovagal syncope and pacing trial (Synpace). A randomized placebo-controlled study of permanent pacing for treatment of recurrent vasovagal syncope. Eur Heart J 2004;25: 1741-8
10. Sud S, Massel D, Klein GJ, Leong-Sit P, Yee R, Skanes AC, et al. The expectation effect and cardiac pacing for refractory vasovagal syncope.AmJMed 2007;120:54-62
11. Brignole M, Vardas P, Hoffman E, Huikuri H, Moya A, Ricci R, et al. Indications for the use of diagnostic implantable and external ECG loop recorders. Europace 2009;11: 671-87
12. Ungar A, Sgobino P, Russo V, Vitale E, Sutton R, Melissano D, et al. Diagnosis of neurally-mediated syncope at initial evaluation and with tilt table testing compared with that revealed by prolonged ECG monitoring. An analysis from the Third International Study on Syncope of Uncertain Etiology (ISSUE-3) registry. Heart 2013,published online 23 October, 2013
13. van Dijk N, Quartieri F, Blanc JJ, Garcia-Civera R, Brignole M, Moya A, et al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: The Physical Counterpressure Manoeuvres Trial (PC-Trial). J Am Coll Cardiol 2006;48:1652-7.